Product Description: OBI-992 drug-linker is a drug-linker conjugate composed of a TOP I inhibitor Exatecan (HY-13631) and a linker. OBI-992 drug-linker exhibits antitumor property in mouse models and can be used for synthesis of ADC OBI-992[1].
Applications: Cancer-programmed cell death
Formula: C106H162FN9O37
References: [1]Li WF, et al., OBI-992, a Novel TROP2-Targeted Antibody-Drug Conjugate, Demonstrates Antitumor Activity in Multiple Cancer Models. Mol Cancer Ther. 2025 Feb 4;24(2):163-175.
CAS Number: 3039487-10-7
Molecular Weight: 2173.46
Compound Purity: 96.64
Research Area: Cancer
Solubility: DMSO : 100 mg/mL (ultrasonic)
Target: Drug-Linker Conjugates for ADC